Accelerated development of a sars-COV-2 vaccine based on the live vsvag chimeric virus platform
Ended Definitive Contract Awarded Last action
- Contract number
- HDTRA121C0005
- Awardee
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
Defense Threat Reduction Agency
Department of Defense
- Obligated
- $26,261,466
Award facts
- Contract value 100% obligated
- $26,261,466.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- New York, NY 10004, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $960,462 | |
| Funding Only Action | $1,000,000 | |
| Funding Only Action | $3,151,178 | |
| Funding Only Action | $1,136,642 | |
| Supplemental Agreement for work within scope | $5,300,000 | |
| Funding Only Action | -$6,379,740 | |
| Definitize Letter Contract | $7,727,633 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,065,291 | |
| Funding Only Action | $5,843,608 | |
| Original award | $6,456,392 |
Show all 13
About this award
This is a $26,261,466 cost-plus-fixed-fee contract awarded by the Defense Threat Reduction Agency (DTRA) to the International AIDS Vaccine Initiative (IAVI) to accelerate development of a SARS-CoV-2 vaccine based on the live VSV∆G chimeric virus platform. The contract has no set-aside designation. IAVI is working with several subcontractors, including Trustees of Boston University, Merck Sharp & Dohme LLC, Neogenomics Laboratories, Charles River Laboratories Montreal ULC, and the University of North Carolina at Chapel Hill, to provide a range of research, manufacturing, and analytical services to support the vaccine development effort. This contract supports DTRA's mission to counter weapons of mass destruction and advance medical countermeasures against emerging infectious diseases.
Quick answers
Who was awarded contract HDTRA121C0005?
HDTRA121C0005 was awarded to International Aids Vaccine Initiative Inc. by Defense Threat Reduction Agency (Department of Defense) on October 5, 2020.
How much is contract HDTRA121C0005 worth?
The government has obligated $26,261,466 on HDTRA121C0005.
Was contract HDTRA121C0005 competed?
The extent of competition for HDTRA121C0005 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award